159 related articles for article (PubMed ID: 23858960)
1. Induction of apoptosis and inhibition of angiogenesis by PEGylated liposomal quercetin in both cisplatin-sensitive and cisplatin-resistant ovarian cancers.
Long Q; Xiel Y; Huang Y; Wu Q; Zhang H; Xiong S; Liu Y; Chen L; Wei Y; Zhao X; Gong C
J Biomed Nanotechnol; 2013 Jun; 9(6):965-75. PubMed ID: 23858960
[TBL] [Abstract][Full Text] [Related]
2. Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer.
Luo H; Zhong Q; Chen LJ; Qi XR; Fu AF; Yang HS; Yang F; Lin HG; Wei YQ; Zhao X
J Cancer Res Clin Oncol; 2008 Sep; 134(9):937-45. PubMed ID: 18350317
[TBL] [Abstract][Full Text] [Related]
3. Millepachine showed novel antitumor effects in cisplatin-resistant human ovarian cancer through inhibiting drug efflux function of ATP-binding cassette transporters.
Wu W; Liu Y; Ye H; Li Z
Phytother Res; 2018 Dec; 32(12):2428-2435. PubMed ID: 30123958
[TBL] [Abstract][Full Text] [Related]
4. Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer.
Gao X; Wang B; Wei X; Men K; Zheng F; Zhou Y; Zheng Y; Gou M; Huang M; Guo G; Huang N; Qian Z; Wei Y
Nanoscale; 2012 Nov; 4(22):7021-30. PubMed ID: 23044718
[TBL] [Abstract][Full Text] [Related]
5. Codelivery of Adriamycin and P-gp Inhibitor Quercetin Using PEGylated Liposomes to Overcome Cancer Drug Resistance.
Yu J; Chen H; Jiang L; Wang J; Dai J; Wang J
J Pharm Sci; 2019 May; 108(5):1788-1799. PubMed ID: 30610857
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma.
Liu Y; Chen L; He X; Fan L; Yang G; Chen X; Lin X; DU L; Li Z; Ye H; Mao Y; Zhao X; Wei Y
Int J Gynecol Cancer; 2008; 18(4):652-9. PubMed ID: 17892458
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable polymeric micelle-encapsulated quercetin suppresses tumor growth and metastasis in both transgenic zebrafish and mouse models.
Wu Q; Deng S; Li L; Sun L; Yang X; Liu X; Liu L; Qian Z; Wei Y; Gong C
Nanoscale; 2013 Dec; 5(24):12480-93. PubMed ID: 24165931
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of 13,14-dihydro-15-deoxy-delta7-prostaglandin-A1-methyl ester integrated into lipid microspheres against human ovarian carcinoma cells resistant to cisplatin in vivo.
Sasaki H; Niimi S; Akiyama M; Tanaka T; Hazato A; Kurozumi S; Fukushima S; Fukushima M
Cancer Res; 1999 Aug; 59(16):3919-22. PubMed ID: 10463583
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells.
Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W
Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522
[TBL] [Abstract][Full Text] [Related]
10. Efficient inhibition of cisplatin-resistant human ovarian cancer growth and prolonged survival by gene transferred vesicular stomatitis virus matrix protein in nude mice.
Zhong Q; Wen YJ; Yang HS; Luo H; Fu AF; Yang F; Chen LJ; Chen X; Qi XR; Lin HG; Wan Y; Chen XC; Wei YQ; Zhao X
Ann Oncol; 2008 Sep; 19(9):1584-91. PubMed ID: 18436522
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer.
Kawaguchi H; Terai Y; Tanabe A; Sasaki H; Takai M; Fujiwara S; Ashihara K; Tanaka Y; Tanaka T; Tsunetoh S; Kanemura M; Ohmichi M
J Ovarian Res; 2014 Apr; 7():38. PubMed ID: 24713296
[TBL] [Abstract][Full Text] [Related]
12. Luteolin sensitizes the antitumor effect of cisplatin in drug-resistant ovarian cancer via induction of apoptosis and inhibition of cell migration and invasion.
Wang H; Luo Y; Qiao T; Wu Z; Huang Z
J Ovarian Res; 2018 Nov; 11(1):93. PubMed ID: 30454003
[TBL] [Abstract][Full Text] [Related]
13. New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid: a comparative study.
Marra M; Salzano G; Leonetti C; Porru M; Franco R; Zappavigna S; Liguori G; Botti G; Chieffi P; Lamberti M; Vitale G; Abbruzzese A; La Rotonda MI; De Rosa G; Caraglia M
Biotechnol Adv; 2012; 30(1):302-9. PubMed ID: 21741464
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells.
Hu J; Wang J; Wang G; Yao Z; Dang X
Int J Mol Med; 2016 Mar; 37(3):690-702. PubMed ID: 26782731
[TBL] [Abstract][Full Text] [Related]
15. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models.
Yuan ZP; Chen LJ; Fan LY; Tang MH; Yang GL; Yang HS; Du XB; Wang GQ; Yao WX; Zhao QM; Ye B; Wang R; Diao P; Zhang W; Wu HB; Zhao X; Wei YQ
Clin Cancer Res; 2006 May; 12(10):3193-9. PubMed ID: 16707620
[TBL] [Abstract][Full Text] [Related]
16. Liposomal quercetin: evaluating drug delivery in vitro and biodistribution in vivo.
Gang W; Jie WJ; Ping ZL; Ming du S; Ying LJ; Lei W; Fang Y
Expert Opin Drug Deliv; 2012 Jun; 9(6):599-613. PubMed ID: 22607534
[TBL] [Abstract][Full Text] [Related]
17. Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro.
Krieger ML; Eckstein N; Schneider V; Koch M; Royer HD; Jaehde U; Bendas G
Int J Pharm; 2010 Apr; 389(1-2):10-7. PubMed ID: 20060458
[TBL] [Abstract][Full Text] [Related]
18. GE11-Directed Functional Polymersomal Doxorubicin as an Advanced Alternative to Clinical Liposomal Formulation for Ovarian Cancer Treatment.
Zou Y; Xia Y; Meng F; Zhang J; Zhong Z
Mol Pharm; 2018 Sep; 15(9):3664-3671. PubMed ID: 29570299
[TBL] [Abstract][Full Text] [Related]
19. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
Shen W; Liang B; Yin J; Li X; Cheng J
Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
